Clinical Trial Update: Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating celecoxib, capecitabine, and irinotecan in recurrent or metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Celecoxib (Celecoxib)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED